Latest filing published 04 Jan 2019 for Lumos Pharma, INC., €8,254.
Insider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Charles J. Link Jr.: trading record in brief
Charles J. Link Jr. is a declared insider of Lumos Pharma, Inc., with filings sourced from SEC (Form 4). In total, 117 filings cover trades dated from 16 November 2011 to 4 January 2019.
In open-market terms, that means 1 purchase worth €1,533 on one side and 93 sales worth €25.5M on the other. Sales outweigh purchases by €25.5M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 13 share grants and 1 option exercise.
The latest filing, published on 4 January 2019, reports a share grant of €8,254 in Lumos Pharma, Inc. The clock since the last published purchase (23 July 2012) now reads 5,221 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Charles J. Link Jr.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,699 shares@ US$1.660.5% of flowCommon StockSEC:0001126234-19-000009:0
- 5,906 shares@ US$1.550.5% of flowCommon StockSEC:0001126234-19-000009:1
- 2,564 shares@ US$0.800.1% of flowCommon StockSEC:0001126234-18-000153:0
- 8,939 shares@ US$8.472.8% of flowCommon StockSEC:0001126234-18-000010:0
- 5,541 shares@ US$10.062.1% of flowCommon StockSEC:0001126234-18-000010:1
- 5,265 shares@ US$10.282.3% of flowCommon StockSEC:0001126234-17-000012:0
- 3,169 shares@ US$11.041.5% of flowCommon StockSEC:0001126234-17-000012:1
- 10,000 shares@ US$20.037.8% of flowCommon StockSEC:0001126234-16-000247:0
- 20,000 shares@ US$17.6814.1% of flowCommon StockSEC:0001126234-16-000237:0
- 5,000 shares@ US$18.603.7% of flowCommon StockSEC:0001126234-16-000237:1
- 11,500 shares@ US$23.8117.0% of flowCommon StockSEC:0001126234-16-000218:0
- 13,500 shares@ US$24.4620.5% of flowCommon StockSEC:0001126234-16-000218:1
- 7,900 shares@ US$33.0616.5% of flowCommon StockSEC:0001126234-16-000208:4
- 46,639 sharesCommon StockSEC:0001126234-16-000208:0
- 1,380 shares@ US$34.463.0% of flowCommon StockSEC:0001126234-16-000208:1
- 17,100 shares@ US$32.2934.9% of flowCommon StockSEC:0001126234-16-000208:3
- 3,621 shares@ US$35.298.0% of flowCommon StockSEC:0001126234-16-000208:2
- 16,405 shares@ US$35.13Common StockSEC:0001126234-15-000199:0
- 1,095 shares@ US$36.50Common StockSEC:0001126234-15-000199:1
- 7,500 shares@ US$38.30Common StockSEC:0001126234-15-000199:2
- 10,000 shares@ US$40.29Common StockSEC:0001126234-15-000186:0
- 5,000 shares@ US$42.55Common StockSEC:0001126234-15-000186:1
- 5,000 shares@ US$43.83Common StockSEC:0001126234-15-000186:2
- 10,000 shares@ US$36.96Common StockSEC:0001126234-15-000179:0
- 5,000 shares@ US$38.17Common StockSEC:0001126234-15-000179:1
25 of 116 declarations